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Scope: Metabolites derived from individual foods found in human biofluids
after consumption could provide objective measures of dietary intake. For
comprehensive dietary assessment, quantification methods would need to
manage the structurally diverse mixture of target metabolites present at wide
concentration ranges.
Methods and results: A strategy for selection of candidate dietary exposure
biomarkers is developed. An analytical method for 62 food biomarkers is
validated by extensive analysis of chromatographic and ionization behavior
characteristics using triple quadrupole mass spectrometry. Urine samples
from two food intervention studies are used: a controlled, inpatient study
(n = 19) and a free-living study where individuals (n = 15) are provided with
food as a series of menu plans. As proof-of-principle, it is demonstrated that
the biomarker panel could discriminate between menu plans by detecting
distinctive changes in the concentration in urine of targeted metabolites.
Quantitative relationships between four biomarker concentrations in urine
and dietary intake are shown.
Conclusion: Design concepts for an analytical strategy are demonstrated,
allowing simultaneous quantification of a comprehensive panel of
chemically-diverse biomarkers of a wide range of commonly-consumed foods.
It is proposed that integration of self-reported dietary recording tools with
biomarker approaches will provide more robust assessment of dietary
exposure.
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1. Introduction
Recent interest in the discovery of ob-
jective biomarkers of dietary intake[1]
has been stimulated by the observation
that metabolites derived from individual
foods are present in post-prandial blood
and urine samples.[2–5] If validated, such
dietary exposure biomarker data could
be used to cross-reference and to com-
plement information derived from tra-
ditional, self-reported dietary assessment
instruments. Importantly, it could help to
reduce the bias which is both pervasive
and hard to quantify in evaluation of ha-
bitual dietary intake. The ideal biomarker
is highly specific to one food item or
food group, it is not detected in the bio-
logical sample of interest when the spe-
cific food item is not ingested, and shows
distinct dose- and time- dependent re-
sponses after consumption of the par-
ticular food.[6] Although some metabo-
lites are associated with exposure to a
defined food or food group, other puta-
tive biomarkers are much less specific
and considerable rigor has to be applied
in any future validation of their utility
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in monitoring dietary intake.[7] For application in the real world,
the key need is to monitor simultaneously as wide a range of
biomarkers as possible to determine the degree of overlap be-
tween foods during any validation process.[8] The issue is com-
plicated because many food-derived chemicals undergo various
modifications during digestion and absorption, or in subsequent
tissue (liver) metabolism, so that the chemical nature of biomark-
ers in body fluids or urine differs from those in the ingested
foods.[9] In human studies, urine is an easily accessible biofluid
that contains relatively high concentrations of many dietary
metabolites or their bio-transformation products.[10] Whilst blood
fractions may be a preferred source of lipid-related biomark-
ers (e.g., fatty acids from dairy products and carotenoids from
vegetables), urine contains a higher abundance or provides bet-
ter discrimination for most of the investigated compounds.[11]
A literature search initiated in 2010 revealed that > 1000 indi-
vidual metabolites had been proposed as putative dietary expo-
sure biomarkers (see Table S1, Supporting Information) in urine,
plasma, and serum. The water-soluble, putative dietary exposure
biomarkers found in urine are derived from a diverse range of
chemical classes found in foods, including di-peptides, simple
amines, aromatic alcohols, carboxylic acids, carnitines, alkaloids,
phenolic acids and are amplified by a wide range of compounds
derived from the microbial catabolism of dietary polyphenols.[9]
Any analytical method that is intended to be used to support
comprehensive dietary exposure assessments should allow si-
multaneous quantification of the structurally diverse mixture of
target metabolites present at a wide range of concentrations in
urine. The advent of ultra-high-performance liquid chromatog-
raphy (UHPLC) columns coupled to highly selective and sen-
sitive triple quadrupole mass spectrometry (QQQ-MS) instru-
ments offers perhaps the best opportunity to develop quantitation
approaches suitable for dietary intake surveys.[12,13] To be useful
for research or for surveying links between nutrition and health,
a panel of dietary biomarkers should be as comprehensive as pos-
sible and include all the key foods and food groups that are con-
sumed habitually by the study population.[7,14] In two recent re-
ports, we have described the design of a food intervention study to
validate biomarkers performance in the context of the typical UK
diet and that included foods processed and prepared in a range of
food formulations.[15,16] Key practical aspects of study design re-
late to the selection of target foods/food groups where biomarker
discovery is feasible and relevant to national policies[15] and the
development of urine sampling methods, suitable for large scale
use in community settings.[16] In the present study we describe
progress toward the development of a rapid, robust, and extend-
able, analytical strategy allowing simultaneous quantification of
a comprehensive panel of chemically diverse potential dietary ex-
posure biomarkers for use in future validation studies.
2. Participants and Methods
2.1. Ethical Approval
The metabolomics at Aberystwyth, Imperial, and Newcastle
(MAIN) project included two major food interventions. In a ran-
domized, controlled, crossover trial (Study 1), participants were
recruited from a database of healthy volunteers at the UK Na-
tional Institute for Health Research (NIHR)/Wellcome Trust Im-
perial Clinical Research Facility (CRF). This study was approved
by the London–Brent Research Ethics Committee (13/LO/0078).
For Study 2, a favorable ethical opinion was obtained following
Proportionate Review by the East Midlands–Nottingham 1
National Research Ethics Committee (14/EM/0040),[15,16] and
Caldicott approval for storage of data and data protection was
granted by Newcastle-upon-Tyne Hospitals NHS Foundation
Trust [6896(3109)]. Study 2 was adopted into the UK clinical
research network portfolio (16 037) and is registeredwith interna-
tional standard randomized controlled trials number, 88 921 234.
All participants in both studies gave written informed consent,
and studies were carried out in accordance with the 1964Declara-
tion of Helsinki and its later amendments or comparable ethical
standards. Study 3 samples were obtained from a pilot random-
ized controlled trial (RCT) for evaluating the effectiveness of a
one-to-one consultation with a GP Practice Nurse to improve
patient lifestyle and reduce the risk of Type-2 diabetes. The trial
was conducted by the Institute of Biological, Environmental and
Rural Sciences (IBERS), Aberystwyth University. A favourable
ethical opinion was obtained from the Wales Research Ethical
Committee (IRAS 239 910) following proportionate review.
2.2. Study Participants and Food Intervention Studies
The first intervention (Study 1) was designed specifically to pro-
vide foods relevant to the World Health Organization (WHO)
healthy eating guidelines[17] at different exposure levels in a con-
trolled, inpatient study.[18] The second intervention study (Study
2)[15,16] involved free-living individuals who were given all their
foods and beverages to prepare and consume at home using fixed
menus that included foods for which putative dietary exposure
biomarkers had been described and for which biomarker mea-
surement was deemed feasible.[15,16] For the controlled, inpatient
study (Study 1) cumulative and spot urine samples were obtained
from 19 healthy individuals aged 21–65 years andmean BMI 25.6
(±3.2 SD kg m−2). Study participants were exposed to menus
providing 25%, 50%, 75%, or 100% of the dietary intake rec-
ommended by the WHO healthy eating guidelines.[17] The same
menu was consumed each day during the 3 days within a sin-
gle treatment period to ensure a stable dietary exposure. Spot
and cumulative urines were collected,[18] including a post-dinner
(PD) sample, 2–3 h after the main evening meal, using single-
use urine containers (International Scientific Supplies Ltd., Brad-
ford, United Kingdom). Urine samples were stored at−80 °C un-
til analysis.
Study 2 was designed to validate putative exposure biomarkers
for commonly consumed foods, typical of UK diets. In two co-
horts of participants, foods were consumed as a series of menus
on 6 different days using a range of food formulation, process-
ing, and cooking methods and participants collected spot urine
samples at home.[15,16] In the second cohort, 15 healthy individ-
uals (aged 21–74 years, mean BMI 24.4 (±2.3 SD kg m−2)) took
part in the food interventions on 3 different days. Participants
were provided with all the food and ingredients to prepare and
consumed meals at home following a series of menus designed
to generate distinctive “Menu Days”. Participants collected urine
samples at pre-determined time points[15,16] including the first
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morning void (FMV) after each menu day. Urine samples were
collected in a plastic jug and a sub-sample was added to a labelled
sterile 30 mL Universal tube and placed in an opaque cool bag in
the fridge at 4 °C. The rest of the urine was discarded. At the
end of the dietary intervention period, all urine samples were
brought to the laboratory in a cool bag. Aliquots (2 mL Eppen-
dorfs) of all urine samples were made and stored at −80 °C until
analysis.
To assess the typical ranges of urinary biomarkers in a free-
living population, multiple FMV urine samples were collected
from individuals (n = 23, aged 45–78 years, BMI range 19.8–46.7
kg m−2) participating in an ongoing clinical trial (Study 3) who
collected three FMV urine samples on non-consecutive days
for each of 3 consecutive weeks (total 9 urine samples). Urine
samples for each participant in Study 3 were normalized by
refractive index (see below) and then pooled, to create a single
sample that reflected each individual’s habitual diet over a
3-week period. These samples were used to obtain the typical
concentration range of individual biomarkers in real world (i.e.,
non-dietary intervention) conditions.
2.3. Strategy for Selection of Candidate Dietary Exposure
Biomarkers
The selection of biomarkers was initiated with a literature search
to generate an initial “long list” of food-related metabolites with
potential for inclusion in a panel of biomarkers that would pro-
vide comprehensive coverage of food items consumed in Stud-
ies 1 and 2. The search was carried out using Google Scholar
and Web of Knowledge using the following search terms in a
range of combinations ‘biomarkers + blood + urine + food +
dietary. Publications were screened and information was added
to the database if they contained data relating to potential dietary
exposure biomarkers measured in either blood (mainly plasma)
or urine samples (see Table S1, Supporting Information). Exam-
ination of the database revealed several major trends. First, of
1153 reported candidate biomarker signals, 976 were discovered
in urine and of 155 putative food intake biomarkers reported to
be present in plasma/serum, 39 were also found in urine. Based
on these data, we focused on urine as a sample type for develop-
ment of a food intake biomarker panel.
More detailed analysis of the food-related metabolite database
revealed that >42% of urinary metabolite signals with dietary
exposure biomarker potential were phase II biotransformation
products including 120 glucuronides/di-glucuronides, 108 sul-
fates, and 15 mixed glucuronide/sulfates (Table S1, Supporting
Information). With few exceptions, chemical standards for these
conjugated metabolites are not available routinely. For these rea-
sons, we restricted the initial list of biomarker candidates (see
Table 2) to metabolites for which chemical standards were read-
ily available at reasonable cost (<$100 per mg) and which were
stable in calibration stock solutions. Although a few publications
reported the use of nuclear magnetic resonance or GC-MS tech-
nologies, the majority (>80%) of biomarker signals were quanti-
fied using an LC-MS-based method. Based on these data we fo-
cused our analytical approach on the use of LC-MS with a stan-
dard range triple quadrupole (QQQ) mass spectrometer to inves-
tigate the applicability of these methodologies.
2.4. Processing of Urine Samples
Urine samples stored at −80 °C were thawed at room temper-
ature. Samples were vortexed and 800 µL of each sample was
transferred to a clean 2 mL Eppendorf tube. Samples were cen-
trifuged (EBA 12R, Hettich Zentrifugen) at 14 000 rpm for 5 min
at 4 °C, and 200 µL of supernatant was aliquoted onto a refrac-
tometer (OptiDuo 38–53, Bellingham and Stanley) prism surface
for three consecutive specific gravity readings. The refractome-
ter prism surface was rinsed with water and dried with tissue
between measurements. For urine extraction based on specific
gravity correction, urine sampleswere aliquoted according to spe-
cific gravity correction factors (see below) and remaining volume
of ultra-pure (18.2 Ω) H2O was added to make a total volume
of 500 µL before adding 500 µL of methanol.[19] Specific gravity
correction factors were calculated for participant urine samples
as a fold change of each urine specific gravity to the lowest uri-
nary specific gravity measured for that participant. The Eppen-
dorf tube containing urine and methanol was vortexed and then
placed on an orbital shaker (FATSM002, Favorgen Biotech Corp)
for 20 min at 4 °C and 1400 rpm in the dark. Extracted samples
were stored at −80 ºC until further analysis.
2.5. Chemicals and Reagents
The following solvents were used for LC mobile phase and sam-
ple preparation: Acetonitrile (Optima LC/MS grade, Fisher Sci-
entific, UK) and methanol (HPLC grade for LC analysis, primer
trace analysis grade for urine extraction and standards prepara-
tion, Fisher Scientific, UK); ammonium acetate (Optima LC/MS
grade, Fisher Scientific, Belgium); formic acid (FA, for mass
spectrometry, ≈98%, Fluka, Sigma-Aldrich, USA). Water was
ultra-pure water (18.2 Ω) drawn from an Elga Purelab flex wa-
ter purifier system (Taiwan). All chemical standards covering the
biomarker panel had a minimal purity of 98%.
2.6. Sample Analysis by Liquid Chromatography Triple
Quadrupole Mass Spectrometry
Sample analysis was performed on a TSQ Quantum Ultra EMR
QQQ mass spectrometer (Thermo Scientific) equipped with a
heated electrospray ionization source. Samples were delivered
using anAccelaUHPLC system (ThermoScientific) consisting of
autosampler, column heater, and quaternary UHPLC-pump. For
hydrophilic interaction liquid chromatography (HILIC) analysis,
chromatographic separation was performed on a ZIC-pHILIC
(polymeric 5 µm, 150 × 4.6 mm) column (Merck). The mobile
phase consisted of 10 mm ammonium acetate in water: acetoni-
trile (95:5) (A) and 10 mm ammonium acetate in water: Acetoni-
trile (5:95) (B). The gradient program used was as follows: 0 min,
95% B (400 µLmin−1); 15min, 20% B (400 µLmin−1); 15.01min,
20% B (500 µLmin−1); 20min, 20% B (500 µLmin−1); 20.01min,
95% B (500 µL min−1); 25 min, 95% B (500 µL min−1). The
HPLC was carried out in low pressure (≈0–7000 psi) operating
mode with 0 and 650 psi as minimum and maximum pressures,
respectively.
For reverse phase (RP) analysis, chromatographic separation
was performed on a Hypersil Gold (1.9 µm, 200 × 2.1 mm)
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RP- column (Thermo Scientific). The mobile phase consisted of
0.1% formic acid in H2O (A) and 0.1% formic acid in MeOH
(B). The gradient program used was as follows: 0 min, 0% B;
0.5 min, 0% B; 5 min, 60% B; 11 min, 100% B; 13 min, 100%
B; 13.01 min, 0% B; 19 min, 0% B. For RP analysis, the flow
rate was maintained at 400 µL min−1. The UHPLC was car-
ried out in high pressure (≈7000–15 000 psi) operating mode
with 0 and 1000 psi as minimum and maximum pressures,
respectively.
For both chromatographic analyses, column oven and au-
tosampler tray were maintained at 60 and 14 °C, respectively.
To ensure consistent sample delivery, 20 µL were injected us-
ing a 20 µL loop and partial loop injection mode. After each in-
jection, syringe and injector were cleaned using a 10% HPLC
grade MeOH solution in ultra-pure water (1 mL flush volume;
100 µL s−1flush speed, 2 mL wash volume) to avoid sample car-
ryover. Mass spectra were acquired in multiple reaction moni-
toring (MRM) mode, in positive and negative ionization polar-
ities simultaneously using optimized values of collision energy
and tube lens for each MRM transition (Table S2, Supporting In-
formation). Spectra were collected at a scan speed of 0.010 and
0.003 s for HILIC and RP analysis, respectively. A scan width of
0.010m/z units and peakwidth (Q1, Q3) of 0.7 FWHMwere used
for both HILIC and RP analyses.
Raw files (ThermoFisher) were converted to mzML[20] using
msconvert in the ProteoWizard tool kit.[21] All further pro-
cessing of mzML files was performed using the R statistical
programming language.[22] Selected reaction monitoring (SRM)
chromatograms were extracted from mzML files using the
R library, mzR and peaks areas were calculated by extracting
pre-defined chromatographic windows (based on calibration
standards) around each peak apex. Absolute concentrations
were calculated using a nine-point calibration curve (0.006561 to
100 µg mL−1). For each calibration standard a quadratic equation
was used to model the relationship between peak area and
concentration (Table S2, Supporting Information). A squared
fit of log 10-transformed values accommodated best the wide
concentration range for biomarkers in high and low consumers
of target foods, without compromising accuracy and normal
distribution requirements for regression analysis.
The limit of detection (LOD) and limit of quantification (LOQ)
of all chemical standards were calculated as the lowest concen-
tration of each biomarker giving a signal-to-noise ratio of 3:1
and 10:1, respectively within the linear range of each calibration
curve.
2.7. Quality Control Strategy for Target Biomarkers
Reproducibility of the mixture of chemical standards was deter-
mined using the relative standard deviation (RSD) of a multi
component calibration standard and an external urine QC sam-
ple using a ‘master mix’ of pooled samples derived from Study 3.
The external urine QC sample was used in order to deter-
mine the effect of the resultant urine matrix on the repro-
ducibility of selected biomarkers across multiple experiments.
The external QC (as opposed to an experimental QC) allowed
for longitudinal monitoring of RSD without intra experimental
bias.
2.8. Data Analysis
Supervised classification of quantitative metabolite data was per-
formed using random forest (RF) classification using the ran-
domForest package[23] in R.[22] For all RF models, the number
of trees (ntree) used was 1000 and the number of variables con-
sidered at each internal node (mtry) was the square root of the
total number of variables. Accuracy, margins of classification
and area under the receiver operator characteristic (ROC) curve
(AUC) were all used to evaluate the performance of classification
models, as described previously.[24] RF classificationmodels were
plotted following multi-dimensional scaling (MDS). Proximity
measures for each individual observation were extracted fromRF
models and scaled coordinates produced using cmdscale on 1—
proximity. RF selection frequencies were used as the criteria for
determining the explanatory power of individual features using
the methods described by.[25] Selection frequency false positive
rates were calculated using the R package forestControl (available
at http:/github.com/wilsontom/forestControl).
3. Results
3.1. Establishment of a Food Biomarker Selection and Analytical
Strategy
Table 1 summarizes the number of metabolites suggested in cur-
rent literature (Table S1, Supporting Information) to be associ-
ated with exposure to 49 specific foods/food groups used in the
MAIN study (Studies 1 and 2). Urine biomarker leads have been
discovered for the vast majority of food commonly consumed in
the UK with the exception of leafy green vegetables other than
crucifers (e.g., lettuce and spinach), carrots, mushrooms, rice,
eggs, and dairy products in general, with the exception of cheese
(Table 1). It is clear that there is considerable choice in terms of
potential biomarkers, with 25 foods/food groups reported to be
represented by 15 or more putative biomarkers.
Our initial LC-MS analyticalmethods were derived from exam-
ination of protocols compiled from the literature search for candi-
date dietary exposure biomarkers and adapted for targeted, quan-
titativemeasurement on a standard rangeQQQ-MS. As a prelude
to examination of chromatographic behavior in mixtures, the
mass transition parameters for 62 selected putative food exposure
biomarkers were determined individually. For each metabolite,
the ionization mode and SRM parameters of collision energy
and product ion mass were investigated to optimize the signal-
to-noise ratio while also attempting to differentiate isomeric or
isobaric compounds by product ion mass (Table S2, Supporting
Information). Preliminary assessment of the chromatographic
separation characteristics of chemical standards mixtures on
several types of UHPLC columns revealed early elution and poor
resolution of several, more polar, metabolites with potential as
food exposure biomarkers. Such compounds included sucrose,
tartarate, 1- and 3-methylhistidine and the dipeptides anserine
and carnosine which exhibited excellent chromatographic char-
acteristics (Figure 1A,B) when analyzed on HILIC columns.[26]
To ensure inclusion of such metabolites in a comprehensive
biomarker detection and quantitation panel, we adopted the use
of both RP and HILIC columns in all subsequent experiments.
Extensive analysis of chromatographic behavior characteristics
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Table 1. Summary of putative urinary biomarkers for 49 foods and food groups derived from published literature.
Dietary components targeted in MAIN study menus No. of putative
biomarkers
Main biofluid type Main chemical classes
Beverages
Tea 131 Urine Polyphenol-derived conjugates and gallates
Coffee 74 Urine Phenolic acids, alkaloids, terpenes
Confectionary/sweetened drinks
Cocoa products/chocolate 73 Urine Methylxanthines, methylated purines, hydroxyphenyl valeric acid
derivatives
Sugar sweetened soft drinks/confectionary 18 Urine Non-essential amino acids, dipeptides, disaccharides
Artificially sweetened drinks 5 Urine Synthetic disaccharide derivatives
Alcoholic drinks
Alcohol general 8 Serum Fatty acids, uronic acids
Wine 87 Urine Phenolic acids, monocarboxylic acids, valerolactones, gallates
Beer/Lager 2 Serum and urine Phytoestrogen, fatty acids
Fruit and vegetables
General fruit and vegetables 32 Urine Hippuric acids
Spices 46 Plasma Wide range of compounds
Specific fruit
Apple 102 Urine Flavanols, phenylvalerolactones, dihydrochalcones, sugar alcohols,
hydroxycinnamates
Pear 21 Plasma Sugars, sugar acids
Banana 19 Plasma Monoamine derivatives, methoxybenzoate derivatives, organic acids
Grapes 41 Urine Anthocyanin derivatives, dicarboxylic acid, flavanols,
hydroxycinnamic acids, phenylvaleric acid derivatives
Strawberries/red berries 30 Urine Hydroxybenzoic acids, hydroxycoumarins, anthocyanins, furan, and
furanone derivatives
Tomatoes 29 Plasma and Urine Flavanol derivatives, hydroxycinnamic acids, flavanones, steroidal,
and 𝛽-carboline alkaloids
Specific vegetables
Cruciferous vegetables 24 Urine Isothiocyanate derivatives, sulfhydryl compounds, organic acids,
flavone derivatives, carboxylic acids, vitamins
Other leafy greens/spinach/lettuce 8 Plasma Tetrapyrrole derivatives, guanidino derivatives, flavanone derivatives
Carrots 6 Plasma Carotenoids
Onion/garlic 20 Urine Sulfhydryl derivatives, flavanol derivatives
Mushrooms 1 Plasma and serum Histidine derivative
Starchy foods/vegetable protein
Legumes (peas, beans, peanuts) 54 Urine Di- and tri-peptides, amino acid derivatives, vitamin B derivatives
Soy products 11 Urine Isoflavonoids
Nuts 56 Urine Flavanol derivatives, dihydroxyphenylacetic acid derivative,
valerolactones,
Potatoes 5 Serum and urine Glycoalkaloids, nortropane alkaloids
Cereal products, pasta, rice
White bread 9 Urine Acyl-carnitines, benzoxazines
Wholegrain general 41 Urine Alkylresorcinols, dihydroxybenzoic acids, benzoxazinoids
Wholegrain rye 21 Urine Benzoxazinoids, carboxylic acids, dibenzoic acids, caffeoylquinic
acid derivatives
Rice 1 Serum Long-chain fatty acid derivative
Baked or toasted products
Strongly heated foods 11 Urine Pyrrolines, pyridine derivatives
Baked or toasted grain products 1 Urine Pyrroline
Fried foods 15 Urine Furaneols, pyrrolines, furanone derivatives
Smoked foods 8 Urine Syringol derivatives
(Continued)
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Table 1. Continued.
Dietary components targeted in MAIN study menus No. of putative
biomarkers
Main biofluid type Main chemical classes
Eggs and Dairy
General dairy products 7 Plasma Phosphatidyl cholines, non-steroidal oestrogen derivatives
Eggs 1 Serum Unsaturated long-chain fatty acid
Butter 4 Plasma and serum Fatty acids
Cheese and other dairy products 13 Urine Organic acid derivatives, acyl-glycine derivatives, quinoline
derivatives
Meats
General meat 20 Urine Carnitine derivatives, histidine derivatives, hydroxyprolines,
non-protein amino acids
Red meat 20 Urine Histidine derivatives, hydroxyprolines, dipeptides,
Processed meats (inc. cured, smoked) 4 Urine Acylcarnitine, methylthiazolidine derivatives
Poultry 4 Urine Histidine derivatives, dipeptides
Fish (all) 6 serum Amines, long-chain fatty acids, furoic acid derivatives
Fish (oily, fatty) 15 Plasma Amines, long-chain fatty acids, furoic acid derivatives, dipeptides
Fish (white) 4 Plasma and urine Betaine derivatives, carboline derivatives
Shellfish 5 Urine Organic acids, amines
Poultry and fish 2 Urine Dipeptide, histidine derivative
Other meat (offal) 1 Urine Mercapturic acid conjugate
Protein intake and digestion
Protein intake and digestion 37 Urine Aromatic amino acid breakdown products, glutamine conjugates
(e.g., peak shape, tailing, and resolution) and ionization condi-
tions for selected metabolites present at the same concentration
in standard mixtures showed that this combination of columns
allowed separation and simultaneous quantification of the panel
of biomarkers by MRMmethodology (data not shown).
Figure 1 illustrates the behavior of selected food biomarker
candidates in the calibration mixtures on both HILIC (at 100 µg
mL−1) (A and B) and RP (at 30 µgmL−1) (C andD) to demonstrate
some general concepts relevant to the design of a biomarker
panel providing comprehensive coverage of dietary exposure.
Most biomarkers chosen for validation showed good symmetry
and narrow peaks with little evidence of tailing; however, there
is clear evidence of overlap from the MRM traces which influ-
ences absolute quantification. Where possible, biomarker can-
didates with poorer chromatographic qualities could be omitted
frompanels and quantitation should focus on relatedmetabolites
with better performance (e.g., 3-methyl xanthine could be used in
preference to 7-methyl xanthine; Figure 1C peaks 13 and 12, re-
spectively). Differences in ionization efficiency (and hence signal
intensity) between putative biomarkers is an important consid-
eration when that metabolite is usually present at low concen-
trations. The use of two or more phase II metabolism products
may be valuable if there is evidence of differential biotransfor-
mation between individuals due to genotypic effects (e.g., fer-
ulic acid-4-O-𝛽-d-glucuronide and ferulic acid-4-O-sulphate; Fig-
ure 1C peaks 15 and 17). For biomarkers expected to be present
in high concentrations, it may be valuable to utilize two related
molecules (especially where each is found at different concen-
trations) to ensure that at least one target is quantifiable within
the linear range of the calibration curve (e.g., hippuric acid and
4-hydroxy hippuric acid; Figure 1C peaks 18 and 14).
3.2. Validation of an Analysis Strategy for Dietary Exposure
Biomarkers on Reverse Phase and Hydrophilic Interaction Liquid
Chromatography Columns
For both HILIC and RP analyses, chemical standard calibration
mixtures were used to quantify biomarker concentrations for
each batch of samples. The LOD and LOQ of candidate biomark-
ers were determined (Table 2). The concentrations of the full
panel of biomarkers were measured in pooled (N= 9) urine sam-
ples from each of 23 free-living participants in Study 3 (Table 2).
The median concentrations ranged across 5 orders of magni-
tude from >1 mg per mL for hippurate and creatinine to ap-
proaching nanogramme levels for other metabolites (e.g., 1,3-
benzoxazol-2-one (BOA), chlorogenic acid, and d,l-sulforaphane
l-cysteine) with the vast majority metabolites falling in the range
0.05–100 µg mL−1. With the exception of quercetin and vanillic
acid, the median concentrations in urine pools were above the
LOQ for each biomarker.
QCmeasurements of calibration standards and urineQC sam-
ples (Figure 2A) showed a clear performance improvement when
utilizing RP chromatography versus HILIC. In a standard cal-
ibration mix, 32 biomarkers measured under RP chromatogra-
phy conditions were below 20% RSD, with 12 of the 32 < 10%
and no biomarkers > 30%. Biomarkers measured under HILIC
conditions showed similar reproducibility, but with 3 biomarkers
> 30%. When reproducibility was measured in a standard urine
QC sample, there were higher RSD values for some biomarkers
(in total 16 out of 62> 30%). To further quantify the reproducibil-
ity of biomarkers, RSD values were measured following repeated
acquisitions of a urine QC sample over a 14 days period (Fig-
ure 2B). Although inter-day RSD values were higher, the median
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Figure 1. . Chromatographic representation of urinary biomarkers for HILIC and RP methods for selected foods and food groups A) HILIC, citrus,
grape, sugary foods, and drinks. B) HILIC, red meat, poultry, white fish, and oily fish. C) RP-C18, fruits and vegetables, flavonoid-rich and anthocyanin
rich foods, crucifers, cocoa products and coffee. D) RP-C18, whole grain foods, sourdough, strongly heated (baked) foods, soy. Where: (1) proline
betaine, (2) 4-hydroxyproline betaine, (3) d-sucrose, (4) l-tartarate, (5) creatinine, (6) trimethylamine-N-oxide, (7) carnitine, (8) 1-methylhistidine, (9)
3-methylhistidine, (10) l-anserine, (11) carnosine, (12) 7-methylxanthine, (13) 3-methyl xanthine, (14) 4-hydroxyhippuric acid, (15) ferulic acid-4-O-𝛽-
d-glucuronide, (16) d,l-sulforaphane-N-acetyl-l-cysteine, (17) ferulic acid-4-O-sulfate, (18) hippuric acid, (19) feruloylglycine, (20) quercetin-3-O-𝛽-d-
glucuronide, (21) 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA)-3-sulfate, (22)N-(2-furoyl)glycine, (23) DHPPA, (24) BOA (1,3-benzoxazol-2-one),
(25) daidzein.
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Table 2. Limit of Detection (LoD), limit of quantification (LoQ), and summary of concentration ranges of dietary biomarkers in urine collected from
free-living individuals in Study 3.
Biomarker Dietary component Concentration Concentration in urine
LoD LoQ Median Min Max
[µg mL−1] [µg mL−1]
Hippuric acid Fruit and vegetables 0.00059 0.00197 2380.68 1011.08 3421.68
Creatinine Meat 0.00009 0.00030 1993.81 614.06 6291.30
Phenyl-acetyl-l-glutamine Protein 0.00164 0.00548 124.52 13.65 338.22
Indoxyl-sulfate Protein (colon fermented) 0.00011 0.00036 106.20 25.48 325.00
7-Methyl-xanthine Cocoa 0.00048 0.00158 97.88 16.40 390.09
1-Methyl histidine Meat 0.00142 0.00472 96.92 22.51 270.28
Trimethylamine-N-oxide Seafood 0.00009 0.00030 78.63 0.13 356.67
3-Methyl histidine Poultry/fish 0.00114 0.00381 60.23 4.31 223.97
Caffeine Coffee/cocoa 0.00011 0.00036 55.67 3.79 162.31
N-(2-Furoyl)glycine Strongly heated foods 0.00075 0.00250 49.71 11.49 105.46
Ferulic acid-4-O-sulfate Coffee 0.00087 0.00289 47.32 13.20 116.98
Feruloylglycine Coffee 0.00234 0.00779 46.68 9.72 218.19
p-Cresol-sulfate Protein (colon fermented) 0.00034 0.00112 32.92 0.23 142.91
l-Histidine Protein intake 0.00024 0.00081 27.49 6.58 102.13
Trigonelline Legumes 0.00114 0.00381 13.02 2.82 77.53
Pyrogallol Legumes 0.00262 0.00872 0.01 0.00 5.28
Taurine Meat 0.00298 0.00993 11.40 0.09 68.80
Carnitine Meat 0.00007 0.00024 10.78 0.83 62.09
Acesulfame-K Sweetener 0.00013 0.00042 10.16 0.00 694.74
3-Hydroxyhippuric acid Fruit and vegetables 0.00059 0.00197 9.59 2.14 48.72
4-Hydroxyhippuric acid Fruit and vegetables 0.00059 0.00197 9.00 3.28 54.20
Caffeic acid Cocoa/tea 0.00133 0.00443 8.29 2.39 15.65
p-Cresol-glucuronide Protein (colon) 0.00017 0.00055 8.12 0.07 67.87
Proline betaine Citrus 0.00114 0.00381 7.25 0.07 89.79
Tartarate Grapes 0.00087 0.00289 5.94 0.04 60.48
DHBA-3-O-sulfate Whole grain 0.00059 0.00197 4.71 0.67 52.38
3-Methyl-xanthine Cocoa 0.00234 0.00779 3.87 0.52 18.38
Quercetin-3-O-b-d-glucuronide Onion 0.00169 0.00564 3.35 0.15 31.19
l-Tryptophan Protein Intake 0.00006 0.00018 2.48 0.47 10.60
Sucrose Sugary foods and drinks 0.00044 0.00146 2.45 0.01 60.80
l-Phenylalanine Protein Intake 0.00009 0.00030 2.20 0.18 7.39
l-Anserine Chicken 0.00028 0.00093 2.04 0.21 19.74
Rhamnitol Apple 0.00046 0.00152 1.77 0.01 0.54
Carnosine Meat 0.00009 0.00030 1.39 0.52 6.20
Ferulic acid Polyphenol rich foods 0.00169 0.00564 1.28 0.19 4.06
Dopamine-4-O-sulfate Banana 0.01181 0.03957 1.11 0.58 6.02
4-Hydroxyproline-betaine Citrus 0.00048 0.00158 1.24 0.05 18.70
Ferulic acid-4-O-b-d-glucuronide Polyphenol rich foods 0.00206 0.00687 1.09 0.29 6.02
Furaneol Red berries 0.00289 0.00964 0.28 0.13 2.02
DHBA Wholegrain 0.00142 0.00472 1.08 0.16 2.49
DHPPA Wholegrain 0.00059 0.00197 1.06 0.29 2.91
d,l-Sulforaphane-N-acetyl-l-cysteine Cruciferous Vegetables 0.00059 0.00197 0.97 0.01 30.40
DHPPA-3-sulfate Whole grain 0.00087 0.00289 0.85 0.21 3.65
Calystegine A3 Potatoes 0.00142 0.00472 0.55 0.03 2.40
Ethyl-beta-d-glucuronide Alcohol 0.00014 0.00047 0.43 0.06 35.83
Dopamine-3-O-sulfate Banana 0.01181 0.03957 0.04 0.00 0.29
(Continued)
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Table 2. Continued.
Biomarker Dietary component Concentration Concentration in urine
LoD LoQ Median Min Max
[µg mL−1] [µg mL−1]
b-Alanine Meat 0.00065 0.00217 0.37 0.03 1.66
Calystegine B2/B1 Potatoes 0.00011 0.00036 0.35 0.01 1.16
Dihydrocaffeic acid Cocoa 0.00059 0.00197 0.17 0.02 2.78
Gallic-acid Fruit/grapes/tea 0.00234 0.00779 0.15 0.03 1.20
Resveratrol Wine 0.00048 0.00158 0.12 0.25 7.16
Chlorogenic acid Coffee 0.00222 0.00741 0.10 0.00 0.89
d,l-Sulforaphane l-cysteine Cruciferous vegetables 0.00024 0.00081 0.08 0.00 3.10
Epicatechin(-) Polyphenol rich foods 0.00257 0.00858 0.03 0.00 1.51
p-Coumaric acid Grapes/berries 0.00006 0.00018 0.03 0.01 0.41
Protocatechuic acid Anthocyanin rich foods 0.00059 0.00197 0.03 0.03 1.57
m-Coumaric acid Coffee 0.00011 0.00036 0.02 0.00 0.32
Daidzein Soy 0.00114 0.00381 0.02 0.00 4.31
Naringenin Citrus 0.00009 0.00030 0.01 0.00 0.33
BOA (1,3-Benzoxazol-2-one) Wholegrain/rye 0.00011 0.00036 0.01 0.00 0.04
Quercetin Onion 0.00142 0.00472 0.00 0.00 0.03
Vanillic acid Cocoa 0.00242 0.00806 0.00 0.00 0.01
value was 19.95% and most values were below the arbitrary 30%
RSD threshold often adopted in the literature.[27]
3.3. Use of Biomarker Panel to Detect Exposure to Targeted
Foods in a Free-Living Study Cohort
To explore the utility of a quantitative biomarker panel to char-
acterize eating habits within populations, we measured the con-
centrations of dietary exposure biomarkers in FMV urine sam-
ples obtained the day after following consumption of 3 dis-
tinctive meal plans (see Table S3A, Supporting Information,
for menu details) in a food intervention study (Study 2).[15,16]
The data were initially subjected to multivariate analysis using
RF decision trees.[28] Figure 3A shows a MDS of RF proxim-
ity values for multinomial classification of liquid chromatogra-
phy triple quadrupole mass spectrometry (LC-QQQ-MS) urinary
panel biomarker concentrations after the threemenu days. These
data demonstrate distinctive groupings of urine samples repre-
senting each daily intervention diet as evidenced by the ROC
curves in Figure 3B illustrating 100% specificity and sensitivity.
The average concentrations in FMV urines of individual (or
combinations of) biomarkers putatively indicative of exposure to
specific foods/food groups within the threemenu days are shown
in Figure 4. The relative levels of biomarkers correspond well
with consumption of foods targeted on eachmenu day. For exam-
ple, in relation tomeat, 3-methylhistidine is strongly indicative of
eating chicken on menu day 1, TMNO reports fish/shellfish ex-
posure on menu day 2, whilst carnosine levels associated with
red meat consumption are highest following consumption of
a 100% beef burger on menu day 3. The relative exposure to
overall protein in the diet is correlated well with the total con-
centration of aromatic amino acids in FMV urine. Exposure to
multiple potato products on menu days 2 and 3 can be mon-
itored by total calystegine content; in this case biomarker sig-
nals above baseline levels are also visible on menu day 1 due to
carry over from foods consumed the previous day, depending on
the randomization of the order of exposure to each menu day
(data not shown). A similar pattern is evident with other foods
commonly used as constituents of complex meals, including
tomato and onion (quercetin), processed meats (carnitine), and
baked/roasted products (N-2-furoyl-glycine). Several biomarkers
show a very strong specificity to individual foods/food groups
that are eaten less frequently, including grape products (tar-
trate), strawberries (furaneol), cocoa products (3- and 7-methyl
xanthine), brassicas (d-l-sulforaphane-N-acetyl-l-cysteine), and
artificially-sweetened drinks (acesulfame-K). Several biomarkers
show some overlap between target foods. For example, pyrogallol
is a biomarker of general legume dietary exposure but the pres-
ence of daidzein in the same urine samples indicate that soya
products have been consumed specifically on menu day 3. Sim-
ilarly, the levels of DHPPA and DHPPA sulfate on menu days
1 and 3 correlates with exposure to whole grain foods, but ele-
vation also of BOA on the latter day suggest that rye-containing
food products specifically have been eaten.
3.4. Use of Biomarkers to Quantify Dietary Exposure
We have reported previously,[18] an inpatient, randomized, con-
trolled, crossover food intervention (Study 1) in which 19 partici-
pants consumed experimental diets that met 25%, 50%, 75%, or
100% of the dietary intake recommended by the WHO healthy
eating guidelines through systematic differences in intakes of
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Figure 2. Reproducibility of biomarker measurement. A) Summary of relative standard deviation (RSD) thresholds from reproducibility testing of
biomarkers in a calibration standard mixture and urine quality control samples derived from Study 3. B) Distribution of RSD values for external urine
QC samples measured repeatedly over 14 days. Dashed red line indicates the median value (19.95%) and the black dashed line is the arbitrary 30%
threshold. Four biomarkers were omitted from the RSD analysis as in this specific population pooled sample the concentrations were < LoQ.
fruits, vegetables, and whole grain foods. For example, grape
products, cocoa-containing products, whole grain foods, and cru-
ciferous vegetables were consumed at four different exposure
levels (Table S3B, Supporting Information). When measured by
UHPLC coupled to a QQQ-MS instrument, the concentrations
in post-dinner spot urine samples of biomarkers selected to
quantify exposure to each of the foods/food groups (l-tartarate,
7-methyl xanthine, DHPPA-3-sulfate and d,l-sulforaphane-N-
acetyl-l-cysteine, respectively) correlated well with the level of
consumption (Figure 5).
4. Discussion
A consensus-based procedure for systematic validation of
biomarkers of dietary intake has been proposed recently. This
procedure stresses the importance of evaluating key criteria
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Figure 3. Detection of differential daily dietary exposure using a panel of urine biomarkers. A) Multi-dimensional scaling (MDS) of random forest
proximity extracted from a classification model of 15 individuals consuming experimental diets in 3 separate treatment periods, and a selected panel of
58 dietary biomarkers. Each symbol represents the urine metabolome of an individual participant on a specific menu day. B) Individual receiver operator
characteristic (ROC) curves illustrating classification performance to discriminate urine samples from each menu day.
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Figure 4. Dietary exposure biomarker concentrations in FMV urine following consumption of 3 distinctive menu plans. Bar charts show average
biomarker concentration (µg mL−1) in normalized FMV urine samples (n = 15) after exposure to menu plans (Table S3A, Supporting Information:
M1 =menu day 1, M2 =menu day 2, M3 =menu day 3). Major meal components consumed on each menu day are summarized at the bottom of the
figure.
including dose- and time-responsiveness, robustness, analytical
performance, and inter-laboratory reproducibility.[29] Although
exhaustive validation of individual biomarkers for specific foods
is clearly important, because the whole dietary pattern may in-
fluence health outcomes,[30,31] there is also considerable interest
in evaluating overall eating habits within populations.[32,33] This
demands development of a comprehensive panel of biomarkers.
As a step toward this objective using urine-based dietary intake
biomarkers, we have demonstrated that the chromatographic res-
olution and sensitivity provided by 2 standardized MRM LC-
QQQ-MS/MS methods is sufficient to enable routine separa-
tion and quantification of complex mixtures of dietary-related
metabolites spanning a wide range of polarities and several or-
ders of magnitude in concentration. Observations made during
the present study allow determination of biomarker attributes
that impact on decisions concerning their eventual inclusion in
a validated panel for routine use in the future.[29]
For a dietary exposure biomarker panel to have real-world util-
ity, coverage should include all those foods that are consumed fre-
quently and/or in large amounts by the population under study
plus any key foods and food groups that have particular (health)
significance.[11,32,34,35] This ambition has to be balanced by the
need to be realistic about those eating behavior factors that influ-
ence the feasibility of obtaining accurate measurement. This will
be a particular constraint for foods that are consumed in small
amounts and/or infrequently and when using one, or few, urine
samples per participant.[36] Importantly, since very few metabo-
lite markers are unique to individual foods, future validation
studies will need to be able to examine simultaneously the be-
haviors of multiple biomarker candidates in the context of a di-
verse a range of dietary intake. As a step toward this objective,
we have described the selection of target foods/food groups and
the development and implementation of food intervention study
designs to represent the UK diet,[15,16] together with the develop-
ment of urine sampling methods, suitable for large scale use in
community settings.[37,38] Using urine samples and dietary expo-
sure records from these intervention studies, in the present study
we have demonstrated that simultaneous, quantitative monitor-
ing of several biomarkers already known to have high specificity
for foods commonly consumed in the UK (including whole grain
products, cruciferous vegetables, cocoa, and grape products) is
feasible using LC-MS/MS. In circumstance where biomarkers
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Figure 5. Boxplots of urinary concentrations of food intake biomarkers. Where, A) l-tartarate, B) 7-methyl xanthine, C) 3-(3,5-dihydroxyphenyl)-1-
propanoic acid (DHPPA-3-sulfate), D) d-l-sulforaphane-N-acetyl-l-cysteine) following graded intakes of specific foods under controlled conditions from
Study 1. Menu plans for days representing none, low, medium, and high exposure to the target foods are shown in Table S3B, Supporting Information.
are associated with exposure to more than one food group (e.g.,
trigonelline reports exposure to both legumes and coffee) then
understanding signal ratios in relation to other putative biomark-
ers will be important during future validation as described re-
cently for discrimination of meat exposure[39]
The routine implementation of a comprehensive dietary ex-
posure monitoring tool requires control of the major sources of
variability, both biological and technical. From a biological per-
spective, some dietary chemicals undergo different metabolic
fates as a result of inter-individual differences in micro-
biome/endogenous metabotype within populations. This prob-
lem may be overcome by measuring an appropriate combina-
tion of signals (metabolites) as highlighted in recent reports.[40–43]
For example, the chemical complexity of the urine metabolome
caused by endogenous glucuronidation and sulfation activities is
well documented.[44,45] It is also important to address the variabil-
ity associated with human micturition behavior. In several stud-
ies, we have shown that analysis of FMV spot urine samples is
highly informative of dietary exposure and that, as well as be-
ing much easier to collect and transport, FMV urine is an ade-
quate substitute for 24 h urine collection.[16,36–38] Normalization
of the concentration of individual spot urine samples by addition
of an appropriate amount of water, guided by simple refractom-
etry measurements, has proved to be effective in facilitating rou-
tine analysis of large numbers of samples.[19]
In the present study we have described quantitative ap-
proaches using QQQ-MS to measure biomarker abundance
which are dependent on the use of complex mixtures of chem-
icals standards for calibration. Others have shown that similar
approaches for “quantitative dietary fingerprinting,” particularly
for polyphenol-derived metabolites, are feasible using less sensi-
tive hybrid quadrupole/ion trap technology when combined with
urine concentration by solid phase extraction methodology.[43]
Commercial availability, purity, stability, solubility, and cost of a
chemical standard are important considerations in the adoption
of any biomarker for inclusion in a standardized biomarker
panel. In the present investigation, intra- and inter-day re-
producibility of quantification of QC samples was excellent.
However, it was more challenging to achieve the same levels of
accuracy and precision with real-world urine samples because
constituents targeted for quantification exhibited unexpected
ionization behaviors on occasion, potentially due to interference
by other urine constituents. However, future validation studies
should examine the behavior of alternative putative biomarkers
in relation to expected concentration ranges within a population
and should consider the frequency of unexpected ionization
behavior caused by coeluting compounds when making final se-
lections. We suggest that the analysis of the behavior of putative
biomarkers in a “master mix” of urine samples representative of
the study population is a valuable step in the selection process.
In conclusion, the analytical methodology outlined in the
present study provides a useful framework for developing and
validating panels of comprehensive biomarkers with utility in
real-world assessment of dietary exposure within free-living
populations. Such approaches could be used to validate, and to
complement, information derived from traditional, self-reported
dietary assessment instruments. This will help to mitigate the
pervasive, and difficult to quantify, problems of participant
misreporting, bias, and inaccuracies of dietary recording and so
improve future nutrition studies.
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